Processing of cardiac valve allografts: 2. Effects of antimicrobial treatment on sterility, structure and mechanical properties

Cell and Tissue Banking

Volumn 3, Issue 2, 2002, Pages 91-103

  Farrington, M ^a   Wreghitt, T ^a   Matthews, I ^a   Scarr, D ^a   Sutehall, G ^a   Hunt, C J ^b   Santiago, T ^c   Gruys, E ^d   Voorhout, W ^d   Ramos, T ^c   Pegg, D E ^e  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b East Anglia Blood Centre   (United Kingdom)

^c Instituto do Coracao   (Portugal)

^d UTRECHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Banking; Cardiac; Disinfection; Heart; Sterilization; Valve

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; AGAR; ALCOHOL; AMPHOTERICIN; ANTIINFECTIVE AGENT; AZTREONAM; BALANCED SALT SOLUTION; CETRIMIDE; CHLORINE DIOXIDE; COLLAGEN; DETERGENT; ELASTIN; ESCULIN; GENTAMICIN; GLYCEROL; MANNITOL; NEOMYCIN; PERACETIC ACID; SODIUM CHLORIDE; SOLVENT; SURFACTANT; TRIBUTYL PHOSPHATE; TRITON X 100; VANCOMYCIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIMICROBIAL THERAPY; AORTA VALVE REPLACEMENT; ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BIOMECHANICS; CELL DAMAGE; CLEANING; CONCENTRATION RESPONSE; CONNECTIVE TISSUE; CONTROLLED STUDY; CRYOPRESERVATION; DISINFECTION; ELASTICITY; ENDOTHELIUM CELL; EXPOSURE; FIBROBLAST; HEART MUSCLE; HEART PRESERVATION; HEAT TREATMENT; IMPLANT; IN VIVO STUDY; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SHEEP; STRUCTURE ANALYSIS; TISSUE INJURY; VIRAL CONTAMINATION; VIRUS CULTURE;

EID: 0242432326     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022815013948     Document Type: Article

References (34)

1. Aidulis D., Pegg D.E., Hunt C.J., Goffin Y.A., Vanderkelen A., van Hoeck B. et al. 2002. Processing of ovine cardiac valve allografts: 1. Effects of preservation method on structure and mechanical properties. Cell and Tissue Banking (submitted).
2. Abd-Elfattah A.S., Messier R.H., Domkowski P.W., Jones J.L., Aly H.M., Crescenzo D.G. et al. 1993. Inhibition of adenosine deaminase and nucleoside transport: Utility in a model of homograft cardiac valve implantation processing. J. Thorac. Cardiovas. Surg. 105: 1095-1105.
3. Barret-Boyes B.G., Roche A.H.G. and Whitlock R.M.L. 1977. Six year review of the results of free-hand aortic valve replacement using an antibiotic sterilised homograft valve. Circulation 55: 353-361.
4. Block S.S. 1991. Peroxygen compounds. In: Block S.S. (ed.), Disinfection, Sterilisation and Preservation. 4th edn. Lea and Febiger, London 167-181.
5. Bodnar E., Parker R., Davies J., Robles J. and Ross D.N. 1990. Non-viable aortic homografts. In: Bodnar E. (ed.), Surgery for Heart Valve Disease. ICR, London, pp. 494-500.
6. Brockbank K.G.M., Carpenter J.F. and Dawson P.E. 1992. Effects of storage temperature on viable bioprosthetic heart valves. Cryobiology 29: 537-542.
7. Coates D. 1996. Sporicidal activity of sodium dichloroisocyanourate, peroxygen and glutaraldehyde disinfectants against Bacillus subtilis. J. Hosp. Infect. 32: 283-294.
8. Dychdala G.R. 1991. Chlorine and chlorine compounds. In: Block S.S. (ed.), Disinfection, Sterilisation and Preservation. 4th edn. Lea and Febiger, London 131-151.
9. Eastlund T. 1995. Infectious disease transmission through cell, tissue and organ transplantation: reducing the risk through donor selection. Cell. Transplant. 4: 455-477.
10. Fischlein T., Schutz A., Haushofer M., Frey R., Uhlig A., Detter C. et al. 1995. Immunologic reaction and viability of cryopreserved homografts. Ann. Thorac. Surg. 60: S122-S126.
11. Gavin J.B., Herdson P.B. and Barret-Boyes B.G. 1972. The pathology of chemically sterilized heart valve allografts. Pathol. 4: 175-183.
12. Goffin Y.A.H., Gouveia H.R., Szombathelyi T., Troussaint M.J.M. and Gruys E. 1997. Morphologic study of homograft valves before and after cryopreservation and after short-term implantation in patients. Cardiovasc. Pathol. 6: 35-42.
13. Horowitz B., Bonomo R., Prince A.M., Chin S.N., Brotman B. and Shulman R.W. 1992. Solvent/detergent-treated plasma: A virus-inactivated substitute for fresh frozen plasma. Blood 79: 826-831.
14. Hu J.-F., Gilmer L., Hopkins R. and Wolfinbarger L. 1989. Effects of antibiotics on cellular viability in porcine heart valve tissue. Cardiovas Res. 23: 960-964.
15. Keuhnert M.J., Clarke E., Lockhart S.R., Soll D.R., Chia J. and Jarvis W.R. 1998. Candida albicans endocarditis associated with a contaminated aortic valve allograft: Implications for regulation of allograft processing. Clin. Inf. Dis. 27: 688-691.
16. Kline L.B. and Hull R.N. 1960. The virucidal properties of peracetic acid. Am. J. Clin. Pathol. 33: 30-33.
17. Koneman E.W. and Davis M.A. 1974. Postmortem bacteriology III. Clinical significance of microorganisms recovered at autopsy. Am J. Clin. Pathol. 61: 28-40.
18. Lang S.J., Giordano M.S., Cardon-Cardo C., Summers B.D., Staiano-Coico L. and Hajjar D.P. 1994. Biochemical and cellular characterisation of cardiac valve tissue after cryopreservation or antibiotic preservation. J. Thorac. Cardiovasc. Surg. 108: 63-67.
19. Leaper S. 1984. Synergistic killing of spores of Bacillus subtilis by peracetic acid and alcohol. J. Food Technol. 19: 355-360.
20. Lupinetti F.M., Tsai T.T., Kneebone J.M. and Bove E.L. 1993. Effect of cryopreservation on the presence of endothelial cells on human valve allografts. J. Thorac. Cardiovasc. Surg 106: 912-917.
21. Lynam P.A., Babb J.R. and Fraise A.P. 1995. Comparison of the mycobacterial activity of 2% alkaline glutaraldhyde and Nu-Cidex (0.35% peracetic acid). J. Hosp. Infect. 30: 237-240.
22. Martinez O.V., Malinin T.I., Valla P.H. and Flores A. 1985. Postmortem bacteriology of cadaver tissue donors: An evaluation of blood cultures as an index of tissue sterility. Diag Microbiol. Infect. Dis. 3: 193-200.
23. Missen G.A. and Roberts C.I. 1970. Calcification and cusp rupture in human aortic valve homografts sterilised by ethylene oxide and freeze dried. Lancet 2: 962-964.
24. Mitchell R.N., Jonas R.A. and Schoen F.J. 1995. Structure-function correlations in cryopreserved allograft cardiac valves. Ann. Thorac. Surg. 60: 108-113.
25. Nagington J., Sutehall G.M. and Whipp P. 1983. Tonometer disinfection and viruses. Br. J. Ophthalmol. 67: 674-676.
26. Nowak T., Niedrig M., Bernhardt D. and Hilfenhaus J. 1993. Inactivation of HIV, HBV, HCV related viruses and other viruses in human derivatives by pasteurisation. Dev. Biol. Stand 81: 125-135.
27. O'Brien M.F., Stafford E.G., Gardener M.A.H., Pohlner P.F., Tesar P.J., Cochrane A.D. et al. 1995. Allograft aortic valve replacement: Long-term follow-up. Ann. Thorac. Surg. 60: S65-S70.
28. Piet M.P.J., Chin S., Prince A.M., Brotman B., Cundell A.M. and Horowitz B. 1990. The use of tri(n-butyl)phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation. Transfusion 30: 591-598.
29. Pruss A., Kao M., Kiesewetter H., von Versen R. and Pauli G. 1999. Virus safety of avital bone tissue transplants: evaluation of sterilisation steps of spongiousa cuboids using a peracetic acid-methanol mixture. Biologicals 27: 195-201.
30. Strickett M.G., Barret-Boyes B.G. and MacCullouch D. 1983. Disinfection of human heart valve allografts with antibiotics in low concentration. Pathol 15: 457-462.
31. Wain W.H., Pearce H.M., Riddell R.W. and Ross D.N. 1977. A re-evaluation of antibiotic sterilisation of heart valve allografts. Thorax 32: 740-742.
32. Warwick R.M., Eastlund T. and Fehily D. 1996. Role of the blood transfusion service in tissue banking. Vox Sang 71: 71-77.
33. Waterworth P.M., Lockey E., Berry E.M. and Pearce H.M. 1974. A critical investigation into the antibiotic sterilisation of heart valve homografts. Thorax 29: 432-437.
34. Yankah A.C., Wottge H.-U., Muller-Hermelink H.K., Feller A.C., Lange P., Wessel U. et al. 1987. Transplantation of aortic and pulmonary allografts, enhanced viability of endothelial cells by cryopreservation, importance of histocompatibility. J. Cardiac. Surg 1 (suppl): 209-220.